We showed that levels of ccf nDNA where significantly elevated in breast cancer patients in comparison with a benign disease group and a healthy control group, while levels of ccf mtDNA were significantly elevated in the breast tumor group (malignant and benign) when compared to the healthy control group. This evidence concerns the gene PITX1 and breast carcinoma.